Photo: The Times of India
Central Govt Clears 2 New COVID-19 Vaccine For Emergency Use
Central Government cleared two more vaccine against COVID-19, for emergency use, on December 28. The decision taken during a high-level meeting was welcomed by manufacturers of the two vaccines; CORBEVAX and COVOVAX and an antiviral drug. Notably, CORBEVAX, manufactured by Biological E. Limited passed two Phase III clinical trials on over 3,000 subjects of 18-80 year-old. The company is to begin 100+ million doses from February 2022.
Tags: Covid-19, Covid-19 Vaccine, Biological E, Corbevax, emergency
Courtesy: ANI
Photo: The Conversation
DCGI Approves J&J's Single-Shot COVID-19 Vaccine In India
Big Pharma Johnson &Johnson's to roll out its single-shot Covid Vaccine in India by the next month. Besides, it is being manufactured at 'Biological E' in Hyderabad. However, the officials have received Emergency Use Approval (EUA) from DCGI. Moreover, Vaccine batches will be sent to Central Drugs Laboratory (CDL) and National Centre for Cell Science (NCCS) for final testing by next week.
Tags: Covid Vaccine, Johnson & Johnson, Pharmaceutical, Biological E
Courtesy: News 18
Photo: Business Today
India Soon To Get Its Cheapest COVID Vaccine At Rs 500 For Both Doses
India is likely to get its most affordable COVID-19 vaccine 'Corbevax', which will reportedly be available at Rs 500 for both the doses. Currently in the third phase of trials, the vaccine is being manufactured by Biological E and has been pre-ordered by the Centre as it showed convincing results in the previous trials. The company is expected to secure an emergency-use approval for 'Corbevax' in the coming months.
Tags: Corbevax, Covid-19, Coronavirus Vaccines, Biological E
Courtesy: The Times of India
Photo: Radio Free Europe
India Invites Pakistani Diplomats For COVID Vaccination Offer
As a part of diplomatic goodwill gesture, India has sent invitations to Delhi-based Pakistani delegates for the COVID-19 vaccination offer. However, Pakistan is yet to respond to the offer. Reportedly, Pakistan commenced its inoculation drive with 50,000 doses of Chinese 'Sinopharm' vaccine on February 2. Earlier in December 2020, India toured over 50 foreign diplomats to two vaccine producing sites in Hyderabad - Bharat Biotech and… read-more
Tags: Covid-19 Vaccination, Sinopharm Vaccine, Bharat biotech, Biological E, Hyderabad
Courtesy: WION
